Remove Disease Remove MRI Remove PET Scan
article thumbnail

Characterizing body fat with MRI helps predict Alzheimer's risk

AuntMinnie

CHICAGO -- Characterizing an individual's type of body fat using body MRI can help predict Alzheimer's disease risk up to 20 years before symptoms manifest, according to research results presented December 2 at the RSNA meeting.

MRI 325
article thumbnail

How Diagnostic Imaging is Revolutionizing Early Disease Detection

Professional Radiology

The Power of Diagnostic Imaging in Early Disease Detection Medical imaging is one of the most significant developments in medical science. By allowing doctors to view the inside of the body without the need for surgery, this technology aids in the early detection of diseases. How Does Early Detection Help?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FES-PET shows promise staging patients with low-grade breast cancer

AuntMinnie

Preliminary studies suggest the tracer may also be effective in patients with earlier, more treatable stages of the disease, yet most of these studies have been retrospective and subject to a large risk of bias, the authors noted. The tumor in the right breast (T4N0M0, grade 3 ductal carcinoma) is visible on both PET scans.

PET Scan 283
article thumbnail

FDA approves donanemab for Alzheimer's disease

AuntMinnie

Food and Drug Administration (FDA) has approved Eli Lilly's drug donanemab (Kisunla) for the treatment of early Alzheimer's disease, including mild cognitive impairment or mild dementia. According to clinical trials, amyloid PET scans showed that donanemab reduced amyloid plaques by up to 84% after 18 months of treatment.

Disease 246
article thumbnail

PET/MRI reveals separate Alzheimer’s biomarkers in single scan

AuntMinnie

A PET radiotracer for diagnosing Alzheimer’s disease may also be used to measure vascular brain changes in patients during PET/MRI scans, according to a study published December 7 in the Journal of Nuclear Medicine. The researchers enrolled 20 participants. Image courtesy of the Journal of Nuclear Medicine.

MRI 325
article thumbnail

New tau PET tracer shows promise in Alzheimer’s disease patients

AuntMinnie

PET imaging using a newly developed radiotracer has identified different patterns of brain tau pathology over time in early-onset versus late-onset Alzheimer’s disease patients, according to a study published February 1 in the Journal of Nuclear Medicine. in 15 patients with negative amyloid PET scans; 1.18 in

Disease 325
article thumbnail

CMS proposal covers PET scans for Alzheimer’s disease

AuntMinnie

Read more on AuntMinnie.com Related Reading: FDA grants full approval to Alzheimer's disease drug Leqembi CMS rethinks limit on PET scans for Alzheimer’s disease patients FDA doubles MRI scans needed for Aduhelm patients CMS to limit coverage of new drugs for Alzheimer's disease CMS scrubs rule restricting PET tracer coverage

PET Scan 130